Company Profile

Print
 
www.ferring.com

  Headquartered in Switzerland, Ferring Pharmaceuticals is a research-driven, specialty biopharmaceutical group, active in global markets. The company identifies, develops and markets innovative products in the areas of reproductive health, urology, gastroenterology, endocrinology and orthopaedics. Ferring has its own operating subsidiaries in nearly 60 countries and markets its products in 110 countries. To learn more about Ferring or its products please visit www.ferring.com.
     
 

GENERAL ELECTRIC HEALTHCARE ESPAÑA SA
CALLE GOBELAS 35 
 28023 MADRID
Phone : +34 91 663 2500
Email: francisco.chicagallego@ge.com
Web: www3.gehealthcare.es

  GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our broad expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies, performance improvement and performance solutions services help our customers to deliver better care to more people around the world at a lower cost. In addition, we partner with healthcare leaders, striving to leverage the global policy change necessary to implement a successful shift to sustainable healthcare systems.
     

As a leading global healthcare and diagnostics company, we strive to make advances toward greater certainty for our customers by providing them with cutting-edge technology that makes a real difference. We move to narrow the gap between doubt and confidence and work to achieve both incremental and transformational progress to improve patients' lives.
We are passionate and resolute in our purpose; we call it The Science of Sure. This ethos is extended throughout our core offerings: Breast & Skeletal Health, Diagnostic, and GYNSurgical Solutions. We believe it is our responsibility to offer our customers ever-greater certainty – what we call progressive certainty – by pushing the boundaries of science.
We act with integrity. We innovate with determination. We are Hologic.

     


Natera, Inc.
201 Industrial Road, Suite 410
San Carlos, CA 94070
USA
Tel 1-650-249-9090 | Fax 1-650-730-2272
Natera is a leading genetic testing company that develops and commercializes non-invasive methods for analyzing DNA. The mission of the company is to transform the diagnosis and management of genetic disease.
In pursuit of that mission, Natera operates a CAP-accredited laboratory certified under the Clinical Laboratory Improvement Amendments (CLIA) in San Carlos, CA, and it currently offers a host of proprietary genetic testing services primarily to OB/GYN physicians and fertility centers, as well as to genetic laboratories through its direct sales force, laboratory distribution partners, and licensees that can run tests in their own laboratories and have the data analyzed through Natera's cloud-based Constellation™ software system.

NIPD Genetics is an innovative European biotechnology company active in the field of designing, developing, and manufacturing non-invasive genetic tests.
NIPD Genetics was founded in 2010 as a spin-off from the Cyprus Institute of Neurology and Genetics to commercialize pioneering research work in the field of non-invasive prenatal diagnosis. NIPD Genetics leverages its proprietary genetic and bioinformatics analysis methods to develops novel technologies for prediction and diagnosis of genetic disorders. NIPD Genetics launched the VERACITY non-invasive prenatal test for the detection of trisomies of chromosomes 21, 18, 13, and aneuploidies of X and Y in 2015.

     
 

www.worlddiabetesfoundation.org
 
Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat other serious chronic conditions: haemophilia, growth disorders and obesity. Headquartered in Denmark, Novo Nordisk employs approximately 42,000 people in 77 countries and markets its products in more than 165 countries. For more information, visit novonordisk.com, Facebook, Twitter, LinkedIn, YouTube
Changing Diabetes® is our response to the global diabetes challenge. Through our Changing Diabetes® in Pregnancy programme we work to create awareness of the links between diabetes and pregnancy. Together with diabetes and maternal health communities, and through collaboration with professional societies, like the International Federation of Gynecology and Obstetrics (FIGO), we are working to raise awareness of the challenges and opportunities in addressing GDM and to improve access to diagnosis and care. For more information, visit novonordisk.com/cdip
The World Diabetes Foundation funded by Novo Nordisk also supports projects on diabetes in pregnancy. 
     

 
Nutricia Research is the R&D organization behind Danone Nutricia Early Life Nutrition and Nutricia Advanced Medical Nutrition. We bring health through food to as many people as possible, particularly those who need special care.
Science is at the very heart of our nutrition and health commitment. Thus we focus our skills and resources on research and innovation to deliver evidence-based specialized nutrition to infants, young children, pregnant women, patients and the elderly. This helps individuals to build, establish and preserve their health capital during early life and later in life. 
The main center for Nutricia Research is located on the Utrecht Science Park, The Netherlands, with satellites in Asia, North America and Latin America. Our scientists, nutritionists and technologists operate within a strong worldwide network of global and local partners, all key specialists in their fields, including research institutes, universities, and academic hospitals.

     

PerkinElmer
Diagnostics
Mustionkatu 6
20750 Turku
Finland
Contact person: 
Ms. Tytti Massinen (tytti.massinen@perkinelmer.com)
Tel: +971 50 5027894
 
PerkinElmer is a global company focused on improving the health and safety of people and their environment. Within the field of fetal and maternal healthcare, PerkinElmer offers complete screening solutions including instrumentation, reagents and risk calculation software for early detection of pregnancy related anomalies.
PerkinElmer was chosen as the principal screening partner for ASPRE. Throughout the study, the PerkinElmer DELFIA® Xpress PlGF 1-2-3TM assay was used as an aid in screening for pre-eclampsia in conjunction with maternal history, mean arterial blood pressure (MAP) measurement, and uAD (Uterine Artery Doppler). ASPRE is expected to report in 2017. 
PerkinElmer has recently acquired Vanadis Diagnostics, which is developing a novel non-sequencing, non-PCR based solution for cfDNA analysis. In the future this acquisition will able PerkinElmer to offer a simplified, cost-effective, high-throughput screening test to help facilitate wider access to non-invasive prenatal testing for pregnant women.
Maternal fetal products availability and claims may differ from country to country based on regulations and product approvals. Please check availability with your local distributor.

     

 

Roche Diagnostics International Ltd.
Centralised and Point of Care Solutions
Forrenstrasse 2
6343 Rotkreuz, Switzerland
www.roche-rotkreuz.com

 
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives.
Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.
     

 


 
The Society for Maternal-Fetal Medicine (est. 1977) is the premiere membership organization for obstetricians/ gynecologists who have additional formal education and training in maternal-fetal medicine.  The society is devoted to reducing high-risk pregnancy complications by sharing expertise through continuing education to its 2,000 members on the latest pregnancy assessment and treatment methods. It also serves as an advocate for improving public policy, and expanding research funding and opportunities for maternal-fetal medicine. The group hosts an annual meeting in which groundbreaking new ideas and research in the area of maternal-fetal medicine are shared and discussed.  For more information visit www.smfm.org.
     

 
Wisepress Medical Bookshop
15 Lyon Road
Merton
London
SW19 2RL
Phone: +44 20 8715 1812
marketing@wisepress.com
www.wisepress.com

 
Wisepress.com, Europe’s leading conference bookseller, attend around 200 conferences every year. We have an extensive range of books and journals relevant to the themes of this conference available at our booth. We also have a comprehensive range of STM titles available on our online bookshop. Follow us on Twitter @WisepressBooks.   

 

 

Yuria-pharm LLC
10, Amosova str.
Kyiv, 03141
Ukraine
www.uf.ua/int
www.diaco.it

 
Founded in 1998, «YURiA-PHARM» focused its efforts on production of infusions and as of today is a leading infusion manufacturer not only in Ukraine, but also in CIS. We supply medical facilities with more than 100 items. of blood- and plasma substitute solutions, original infusion drugs, antibiotics, fungicidal drugs, syrups, antiseptics, parenteral nourishment preparations, anti-tuberculosis drugs, syringes, I.V. sets., unique products for osteoarthtrosis treatment. Our product line sums up to more than 40 infusions, completely covering the needs of medical facilities in infusion therapy. Annual turnover of the company exceeds 60 mln bottles.